id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0231-0015,FDA,FDA-2011-N-0231,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2021-05-19T04:00:00Z,2021,5,2021-05-19T04:00:00Z,,2023-09-07T21:10:22Z,2021-10535,0,0,0900006484b1b36a
FDA-2011-N-0231-0013,FDA,FDA-2011-N-0231,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records",Notice,30 Day Proposed Information Collection,2021-02-23T05:00:00Z,2021,2,2021-02-23T05:00:00Z,2021-03-26T03:59:59Z,2023-09-07T21:09:23Z,2021-03541,0,0,0900006484a47c79